The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
NCT00002288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To assess the efficacy of Retrovir (AZT) therapy in the treatment of HIV Ab positive persons with impairments in neuropsychological functioning. To assess the safety, virologic, and immunologic effects of AZT therapy in HIV Ab positive persons with neuropsychological impairment but minimal other symptomatology.
Conditions
- HIV Infections
Interventions
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
Glaxo Wellcome
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Thinking and Memory Problems in People With HIV
NCT01875588 ·Status: RECRUITING
-
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific
NCT00168246 ·Status: UNKNOWN
-
Assessment of Attentional Functioning in Children With HIV-1 Infection
NCT00001497 ·Status: COMPLETED
-
Central Nervous System Disease in HIV-infected Children on HAART
NCT00110331 ·Status: COMPLETED
-
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
NCT00002148 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
NCT01340950 ·Status: COMPLETED ·Phase: PHASE4
-
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
NCT03239899 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients
NCT00893815 ·Status: COMPLETED
-
Effect of Cenicriviroc on HIV Neurocognitive Impairment
NCT02128828 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175
NCT00096824 ·Status: COMPLETED
-
Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning
NCT02308332 ·Status: COMPLETED ·Phase: PHASE4
-
Identification and Quantification of HIV CNS Latency Biomarkers
NCT02989285 ·Status: UNKNOWN
-
Mental Ability Challenge Study in Adults With and Without HIV
NCT03244488 ·Status: COMPLETED
-
Neural Correlates of Working Memory Training for HIV Patients
NCT02602418 ·Status: UNKNOWN ·Phase: NA
-
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
NCT00000883 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570 ·Status: COMPLETED
-
Neurobehavioral Model of HIV in Injection Drug Users
NCT00198861 ·Status: COMPLETED
-
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312 ·Status: ENROLLING_BY_INVITATION
-
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009 ·Status: RECRUITING
-
The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
NCT00540137 ·Status: COMPLETED ·Phase: PHASE4
-
Functional Imaging Reserve in NeuroHIV
NCT03596268 ·Status: COMPLETED
-
Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients
NCT00001048 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Diet on Brain Processing
NCT02835820 ·Status: COMPLETED ·Phase: NA
-
Improving Memory Performance by Applying Cognitive Training
NCT02216591 ·Status: COMPLETED ·Phase: NA